Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

STEVEN ADES

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1972796167
CMS profile
960636
Location
BURLINGTON, VT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$25.70

1 record · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Education $25.70 1

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme LLC $25.70 1

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

STEVEN ADES

NPI 1972796167 · CMS profile ID 960636

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

BURLINGTON, VT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1972796167?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
STEVEN ADES, NPI 1972796167, CMS profile ID 960636. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1972796167?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). STEVEN ADES, NPI 1972796167, CMS profile ID 960636. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1972796167?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
STEVEN ADES, NPI 1972796167, CMS profile ID 960636, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1972796167?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

1 matching record · $25.70 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 1 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–1 of 1.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme LLC $25.7012/12/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1238004914 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $120.04 4
PY2025 $25.70 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $90,833.66 5
PY2024 Principal investigator $189,558.75 28
PY2023 Principal investigator $129,579.24 18
PY2022 Principal investigator $139,160.39 28
PY2021 Principal investigator $82,147.48 26
PY2020 Recipient $4,600.00 2
PY2020 Principal investigator $258,725.27 56
PY2019 Recipient $3,069.83 34
PY2019 Principal investigator $223,598.60 29

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

63 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $1,636.51 12/31/2019 Covered Recipient Teaching Hospital
University Of Vermont Medical Center
A Phase III, Randomized, Open-Label, Multi-Center, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination with Gemcitabine+Cisplatin for Neoadjuvant Treatment Followed by Durvalumab Alone for Adjuvant Treatment in Patients with Muscle-Invasive Bladder Cancer No dispute reported 06/30/2026 685004655
Principal investigator 1 Merck Sharp & Dohme Corporation $6.00 12/09/2019 Non-covered Recipient Entity
RM E213,UNIV OF VERMONT CANCER
PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR No dispute reported 06/30/2026 691540731
Principal investigator 1 EMD Serono, Inc. $1,462.50 12/05/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
EMR 100070-001 No dispute reported 06/30/2026 703034087
Principal investigator 1 EMD Serono, Inc. $1,500.00 10/02/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
MS201781-0031 No dispute reported 06/30/2026 703034159
Principal investigator 1 AstraZeneca Pharmaceuticals LP $18,720.00 09/19/2019 Covered Recipient Teaching Hospital
University Of Vermont Medical Center
A Phase III, Randomized, Open-Label, Multi-Center, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination with Gemcitabine+Cisplatin for Neoadjuvant Treatment Followed by Durvalumab Alone for Adjuvant Treatment in Patients with Muscle-Invasive Bladder Cancer No dispute reported 06/30/2026 685003479
Principal investigator 1 EMD Serono, Inc. $3,406.50 09/18/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
EMR 100070-001 No dispute reported 06/30/2026 703035353
Principal investigator 1 EMD Serono, Inc. $1,500.00 09/11/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
MS201781-0031 No dispute reported 06/30/2026 703034157
Principal investigator 1 EMD Serono, Inc. $3,500.00 09/03/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
MS100070-0176 No dispute reported 06/30/2026 703035389
Principal investigator 1 Eli Lilly and Company $58,390.00 08/26/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
A STUDY OF ABIRATERONE ACETATE PLUS PREDNISONE WITH OR WITHOUT ABEMACICLIB (LY2835219) IN PARTICIPANTS WITH PROSTATE CANCER No dispute reported 06/30/2026 654286969
Principal investigator 1 PFIZER INC. $243.76 07/11/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
PHASE 1 SAFETY PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF PF02341066 A CMETHGFR SELECTIVE TYROSINE KINASE INHIBITOR ADMINISTERED ORALLY TO PATIENTS WITH ADVANCED CANCER No dispute reported 06/30/2026 671657351
Principal investigator 1 Array BioPharma Inc. $1,874.95 07/05/2019 Non-covered Recipient Entity
THE UNIVERSITY OF VERMONT MEDICAL CENTER
A 2-Part Phase III Randomized, Open Label, Multicenter Study of LGX818 plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in Patients with Unresectable or Metastatic BRAF V600 Mutant Melanoma No dispute reported 06/30/2026 704869227
Principal investigator 1 Merck Sharp & Dohme Corporation $0.30 06/10/2019 Non-covered Recipient Entity
UNIV OF VERMONT CANCER
PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR No dispute reported 06/30/2026 691411799
Principal investigator 1 Merck Sharp & Dohme Corporation $2.48 06/10/2019 Non-covered Recipient Entity
UNIV OF VERMONT CANCER
PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR No dispute reported 06/30/2026 691411805
Principal investigator 1 Merck Sharp & Dohme Corporation $38.39 06/10/2019 Non-covered Recipient Entity
UNIV OF VERMONT CANCER
PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR No dispute reported 06/30/2026 691411809
Principal investigator 1 Merck Sharp & Dohme Corporation $4.80 06/10/2019 Non-covered Recipient Entity
UNIV OF VERMONT CANCER
PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR No dispute reported 06/30/2026 691411879
Principal investigator 1 Merck Sharp & Dohme Corporation $40.86 06/10/2019 Non-covered Recipient Entity
UNIV OF VERMONT CANCER
PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR No dispute reported 06/30/2026 691411883
Principal investigator 1 EMD Serono, Inc. $292.50 04/08/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
EMR 100070-001 No dispute reported 06/30/2026 703032341
Principal investigator 1 Eli Lilly and Company $957.52 03/26/2019 Non-covered Recipient Entity
JACKSONVILLE CENTER FOR CLINICAL RESEARCH
A STUDY OF ABIRATERONE ACETATE PLUS PREDNISONE WITH OR WITHOUT ABEMACICLIB (LY2835219) IN PARTICIPANTS WITH PROSTATE CANCER No dispute reported 06/30/2026 654294911
Principal investigator 1 Merck Sharp & Dohme Corporation $27,864.67 03/22/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
A Phase III Randomized, Controlled Clinical Trial of Pembrolizumab with or without Platinum-Based Combination Chemotherapy versus Chemotherapy in Subjects with Advanced or Metastatic Urothelial Carcinoma No dispute reported 06/30/2026 691298081
Recipient EMD Serono, Inc. $3.79 03/09/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029255
Recipient EMD Serono, Inc. $3.79 03/09/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029257
Recipient EMD Serono, Inc. $5.88 03/09/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029321
Recipient EMD Serono, Inc. $5.89 03/09/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029323
Recipient EMD Serono, Inc. $6.48 03/09/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029325
Recipient EMD Serono, Inc. $6.48 03/09/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029327
Recipient EMD Serono, Inc. $24.00 03/09/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029781
Recipient EMD Serono, Inc. $24.00 03/09/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029783
Recipient EMD Serono, Inc. $13.99 03/08/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029563
Recipient EMD Serono, Inc. $13.99 03/08/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029565
Recipient EMD Serono, Inc. $14.84 03/08/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029579
Recipient EMD Serono, Inc. $14.84 03/08/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029589
Recipient EMD Serono, Inc. $14.84 03/08/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029599
Recipient EMD Serono, Inc. $14.84 03/08/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029609
Recipient EMD Serono, Inc. $27.71 03/08/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029929
Recipient EMD Serono, Inc. $27.71 03/08/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029931
Recipient EMD Serono, Inc. $44.96 03/08/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703030243
Recipient EMD Serono, Inc. $44.96 03/08/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703030253
Recipient EMD Serono, Inc. $1.54 03/07/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703028977
Recipient EMD Serono, Inc. $1.54 03/07/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703028979
Recipient EMD Serono, Inc. $6.59 03/07/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029329
Recipient EMD Serono, Inc. $6.59 03/07/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029331
Recipient EMD Serono, Inc. $9.90 03/07/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029383
Recipient EMD Serono, Inc. $9.90 03/07/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029385
Recipient EMD Serono, Inc. $10.99 03/07/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029391
Recipient EMD Serono, Inc. $10.99 03/07/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703029393
Recipient EMD Serono, Inc. $67.45 03/07/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703030653
Recipient EMD Serono, Inc. $67.45 03/07/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703030663
Recipient EMD Serono, Inc. $86.00 03/07/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703031535
Recipient EMD Serono, Inc. $86.00 03/07/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703031541
Principal investigator 1 EMD Serono, Inc. $292.50 03/07/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
EMR 100070-001 No dispute reported 06/30/2026 703032339
Recipient EMD Serono, Inc. $507.00 03/07/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703032745
Recipient EMD Serono, Inc. $507.00 03/07/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703032747
Principal investigator 1 EMD Serono, Inc. $1,462.50 02/25/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
EMR 100070-001 No dispute reported 06/30/2026 703034085
Principal investigator 1 EMD Serono, Inc. $20.53 02/20/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
MS201781-0031 No dispute reported 06/30/2026 703029675
Principal investigator 1 EMD Serono, Inc. $25.00 02/20/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
MS201781-0031 No dispute reported 06/30/2026 703029829
Principal investigator 1 EMD Serono, Inc. $38.53 02/20/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
MS201781-0031 No dispute reported 06/30/2026 703030047
Principal investigator 1 EMD Serono, Inc. $75.00 02/20/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
MS201781-0031 No dispute reported 06/30/2026 703031501
Recipient EMD Serono, Inc. $688.95 02/18/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703033053
Recipient EMD Serono, Inc. $688.95 02/18/2019 Covered Recipient Physician MS201781-0031 No dispute reported 06/30/2026 703033055
Principal investigator 1 PFIZER INC. $972.80 01/31/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
PHASE 1 SAFETY PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF PF02341066 A CMETHGFR SELECTIVE TYROSINE KINASE INHIBITOR ADMINISTERED ORALLY TO PATIENTS WITH ADVANCED CANCER No dispute reported 06/30/2026 671695171
Principal investigator 1 EMD Serono, Inc. $1,500.00 01/17/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
EMR 100070-001 No dispute reported 06/30/2026 703034161
Principal investigator 1 EMD Serono, Inc. $21,905.00 01/15/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
MS 201781-0031 No dispute reported 06/30/2026 703036969
Principal investigator 1 EMD Serono, Inc. $75,865.00 01/02/2019 Covered Recipient Teaching Hospital
UNIVERSITY OF VERMONT MEDICAL CENTER
EMR 100070-001 No dispute reported 06/30/2026 703037245